Botulinum toxin A (Daewoong Pharmaceuticals)

Product Name :
Botulinum toxin A (Daewoong Pharmaceuticals)

Search keywords :
SNAP25

drugId :
null

Target Vo:
Synaptosomal-associated protein 25

Target Vo Short Name :
SNAP-25

Moa_Name:
Synaptosomal-associated protein 25 inhibitors

First Approval Country :
South Korea

First Approval Date Filter:
2013

Origin Company_Name :
Daewoong Pharmaceutical Co Ltd

Active Company_Name :
AEON Biopharma Inc

Active Indication_Name:
Nasolabial fold wrinkles

In Active Indication_Name:
Muscle Spasticity

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Wnt5a Antibody
Atg12 Antibody
SUZ12 Antibody: SUZ12 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to SUZ12. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts